.

These sessions will provide an update on several aspects of the emerging COVID-19 pandemic. This will include current and up-to-date information regarding the disease, as well as the exploration of other medical areas affected by the pandemic. It will address the most recent information and direction from medical organizations within Alberta.

November 2, 2022

• Reflect on the balance between public health measures being lifted and protecting health and wellbeing
• Review vaccine updates, including information and evidence on bivalent vaccine and hybrid immunity
• Recognize the impact of social isolation on seniors in the community and in long term care settings

September 7, 2022

• Summarize current data from community monitoring, including wastewater data, new development with TARRANT Watch, and other provincial initiatives
• Describe outpatient therapeutic options available for COVID-19
• Review the pediatric COVID-19 vaccine evidence and provide practical advice on how to address vaccine hesitancy
• Recognize the trends in emergency room data and respiratory health concerns in children as the school season begins

June 22, 2022

• Describe current public health messaging in Alberta while relating this to observed preventative and vaccination practices
• Summarize the latest evidence of infection-induced immunity and vaccine-induced immunity 
• Recognize emerging understanding around symptomatology of long COVID and connect patients with relevant resources
• Reflect on trends of returning viral infections presentation and behavior after easing of public health measures

March 23, 2022

• Promote an environment for reflection on how COVID-19 has impacted individual and societal expectations, and clinical practices moving forward
• Summarize medical and healthcare accomplishments and lessons learned during the pandemic
• Self-reflect on your experience during the pandemic and support constructive change in our personal and professional lives

January 26, 2022

• Summarize the rationale behind latest public health measures
• Summarize current guidelines for testing, isolation and return to work
• Discuss the emerging evidence for benefit and safety of vaccines and boosters in the pediatric, adult, immunocompromised and elderly sub-populations
• Describe the latest evidence for therapeutic options available for COVID-19 outpatient management
• Implement COVID-19 Guidance for Community Providers and navigate the protocols and availability of cited resources

December 8, 2021

• Discuss the evidence behind non-pharmaceutical interventions (NPIs) and how we should use them in the future
• Examine the evidence behind updated recommendations for vaccination, including in children age 5-11 and need for third doses in adults
• Outline the pharmaceuticals that could be potentially used in the outpatient setting to prevent hospitalization, including oral anti-viral therapies and repurposed medications, as well as, intravenous monoclonal antibodies
• Highlight pathways and other primary care initiatives that can optimize care of patients with COVID-19 in their medical home

November 10, 2021

• Describe the impact of the pandemic on mental health presentation in children and adolescents
• Recognize the importance of early screening and management of mental health disorders in children and adolescents
• Describe the impact of the pandemic on opioid and alcohol substance use disorders in the Alberta adult population
• Summarize key clinical tools and resources available for supporting mental health of patients and families

October 13, 2021 - This session is focused on the physician experience

• List moral dilemmas faced by physicians
• Explain the construct of moral distress
• Describe approaches for dealing with moral dilemmas and their consequences

September 28, 2021 - Special Tuesday Episode

• Explain the challenges assessing pregnant patients with COVID-19 infection
• Summarize treatment recommendations for COVID-19 infection in pregnancy
• Describe effectiveness data supporting the recommendation for COVID-19 vaccination in pregnancy
• Describe safety data supporting the recommendation for COVID-19 vaccination in pregnancy

September 22, 2021

• Describe the therapeutic options available for medical inpatients with COVID19 and when to use dexamethasone, remdesivir, monoclonal antibodies, tocilizumab, therapeutic anticoagulation and prone positioning

• Review the updated DoM-PLP infographic on the inpatient management of COVID19 and additional resources to assist clinicians during the fourth wave

September 8, 2021

• Examine how polarizing positions on public health measures for COVID-19 may be harmful and how a multifaceted approach is preferred
• Debate the ethical and legal considerations of vaccine mandates and passports
• Discuss vaccinations and long COVID in children and how these factor into a safe return to school this fall